Increased plasma levels of IL-6 and IL-8 are associated with surgical site infection after pancreaticoduodenectomy

Pancreas

Volumn 32, Issue 2, 2006, Pages 178-185

  Kimura, Fumio ^a   Shimizu, Hiroaki ^a   Yoshidome, Hiroyuki ^a   Ohtsuka, Masayuki ^a   Kato, Atsushi ^a   Yoshitomi, Hideyuki ^a   Nozawa, Satoshi ^a   Furukawa, Katsunori ^a   Mitsuhashi, Noboru ^a   Sawada, Shigeaki ^a   Takeuchi, Dan ^a   Ambiru, Satoshi ^a   Miyazaki, Masaru ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Chemokines; Cytokines; Pancreaticoduodenectomy; Surgical site infection

Indexed keywords

AMYLASE; CEFMETAZOLE; CHEMOKINE; CYTOKINE; GABEXATE MESILATE; HEAT SHOCK PROTEIN 70; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MAXON; MONOCYTE CHEMOTACTIC PROTEIN 1;

ABDOMINAL ABSCESS; ADULT; AGED; ANASTOMOSIS LEAKAGE; ANTIBIOTIC PROPHYLAXIS; ARTICLE; AUTOANALYZER; BLOOD LEVEL; CANCER; DIAGNOSTIC KIT; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PANCREAS FUNCTION; PANCREAS JUICE; PANCREATICODUODENECTOMY; PERIOPERATIVE PERIOD; PERITONEUM EXUDATE; PERITONITIS; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; STENT; SURGICAL INFECTION; SURGICAL TECHNIQUE; SUTURE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; DUODENUM; FEMALE; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PANCREATECTOMY; PANCREATIC NEOPLASMS; POSTOPERATIVE COMPLICATIONS; SURGICAL WOUND INFECTION;

EID: 33646028253     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpa.0000202959.63977.5c     Document Type: Article

References (34)

1. Kakita A, Yoshida M, Takahashi T. History of pancreaticojejunostomy in pancreaticoduodenectomy: development of a more reliable anastomosis technique. J Hepatobiliary Pancreat Surg. 2001;8:230-237.
2. Gouma DJ, van Geenen RC, van Gulik TM, et al. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg. 2000;232:786-795.
3. Sohn TA, Yeo CJ, Cameron JL, et al. Do preoperative biliary stents increase postpancreaticoduodenectomy complications? J Gastrointest Surg. 2000;4:258-267.
4. Adam U, Makowiec F, Riediger H, et al. Risk factors for complications after pancreatic head resection. Am J Surg. 2004;187:201-208.
5. Suc B, Msika S, Fingerhut A, et al. Temporary fibrin glue occlusion of the main pancreatic duct in the prevention of intra-abdominal complications after pancreatic resection: prospective randomized trial. Ann Surg. 2003;237:57-65.
6. van Berge Henegouwen MI, De Wit LT, Van Gulik TM, et al. Incidence, risk factors, and treatment of pancreatic leakage after pancreaticoduodenectomy: drainage versus resection of the pancreatic remnant. J Am Coll Surg. 1997;185:18-24.
7. Biffl WL, Moore EE, Moore FA, et al. Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation? Ann Surg. 1996;224:647-664.
8. Fiorentino DF, Zlotnik A, Mosmann TR, et al. IL-10 inhibits cytokine production by activated macrophages. J Immunol. 1991;147:3815-3822.
9. van Dissel JT, van Langevelde P, Westendorp RG, et al. Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet. 1998;351:950-953.
10. Gale LM, McColl SR. Chemokines: extracellular messengers for all occasions? Bioessays. 1999;21:17-28.
11. van Berge Henegouwen MI, van der Poll T, van Deventer SJ, et al. Peritoneal cytokine release after elective gastrointestinal surgery and postoperative complications. Am J Surg. 1998;175:311-316.
12. Tanaka T, Matsugu Y, Fukuda Y. Use of ultrasonically activated shears improves the safety of pancreaticojejunostomy after pancreaticoduodenectomy. Arch Surg. 2002;137:1258-1261.
13. Nagai H, Henrich H, Wunsch PH, et al. Role of pancreatic enzymes and their substrates in autodigestion of the pancreas. In vitro studies with isolated rat pancreatic acini. Gastroenterology. 1989;96:838-847.
14. Naruse S, Wang Y, Kitagawa M, et al. Long-term effects of nafamostat and imipenem on experimental acute pancreatitis in rats. Pancreas. 2000;21:290-295.
15. Zhang H, Patel SA, Kandil E, et al. Pancreatic elastase is proven to be a mannose-binding protein - implications for the systemic response to pancreatitis. Surgery. 2003;133:678-688.
16. Yamaguchi T, Miyata M, Kamiike W, et al. Histometric analysis of the distal pancreas in pancreatic head cancer. Surg Today. 1997;27:420-428.
17. Boerma D, Straatsburg IH, Offerhaus GJ, et al. Experimental model of obstructive, chronic pancreatitis in pigs. Dig Surg. 2003;20:520-526.
18. Kimura F, Miyazaki M, Suwa T, et al. Plasma concentration of cytokine antagonists in patients with infection following liver resection. Br J Surg. 1998;85:1631-1635.
19. Topley N, Mackenzie RK, Williams JD. Macrophages and mesothelial cells in bacterial peritonitis. Immunobiology. 1996;195:563-573.
20. Howard M, Muchamuel T, Andrade S, et al. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med. 1993;177:1205-1208.
21. Lehmann AK, Halstensen A, Sornes S, et al. High levels of interleukin 10 in serum are associated with fatality in meningococcal disease. Infect Immun. 1995;63:2109-2112.
22. Ditschkowski M, Kreuzfelder E, Rebmann V, et al. HLA-DR expression and soluble HLA-DR levels in septic patients after trauma. Ann Surg. 1999;229:246-254.
23. Ono S, Tsujimoto H, Hiraki S, et al. Sex differences in cytokine production and surface antigen expression of peripheral blood mononuclear cells after surgery. Am J Surg. 2005;190:439-444.
24. Gale LM, McColl SR. Chemokines: extracellular messengers for all occasions? Bioessays. 1999;21:17-28.
25. Yamada T, Hisanaga M, Nakajima Y, et al. Serum interleukin-6, interleukin-8, hepatocyte growth factor, and nitric oxide changes during thoracic surgery. World J Surg. 1998;22:783-790.
26. Matsukawa A, Hogaboam CM, Lukacs NW, et al. Endogenous MCP-1 influences systemic cytokine balance in a murine model of acute septic peritonitis. Exp Mol Pathol. 2000;68:77-84.
27. Riese J, Schoolmann S, Beyer A, et al. Production of IL-6 and MCP-1 by the human peritoneum in vivo during major abdominal surgery. Shock. 2000;14:91-94.
28. Kimura F, Miyazaki M, Suwa T, et al. Hyperactive cytokine response after partial hepatectomy in patients with biliary obstruction. Eur Surg Res. 1998;30:259-267.
29. Suc B, Msika S, Piccinini M, et al. Octreotide in the prevention of intra-abdominal complications following elective pancreatic resection: a prospective, multicenter randomized controlled trial. Arch Surg. 2004;139:288-294.
30. Konstadoulakis MM, Filippakis GM, Lagoudianakis E, et al. Intra-arterial bolus octreotide administration during Whipple procedure in patients with fragile pancreas: a novel technique for safer pancreaticojejunostomy. J Surg Oncol. 2005;89:268-272.
31. Kimura F, Itoh H, Ambiru S, et al. Circulating heat-shock protein 70 is associated with postoperative infection and organ dysfunction after liver resection. Am J Surg. 2004;187:777-784.
32. Koperna T, Vogl SE, Poschl GP, et al. Cytokine patterns in patients who undergo hemofiltration for treatment of multiple organ failure. World J Surg. 1998;22:443-447.
33. Sato N, Koeda K, Ikeda K, et al. Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer. Ann Surg. 2002;236:184-190.
34. Yeh DC, Wu CC, Ho WM, et al. Bacterial translocation after cirrhotic liver resection: a clinical investigation of 181 patients. J Surg Res. 2003; 111:209-214.